Ruah Alyamany: Evaluating Safety of TPO-RA Use in ITP After Splenectomy
Ruah Alyamany, Advanced Classical (Benign) Hematology Fellow at Mayo Clinic, shared a post on LinkedIn:
“Excited to share our latest study in ITP.
In clinical practice, esp. in classical (benign) hematology, safety and risk can be easily assumed rather than examined. In ITP, many patients receive TPO-RAs after splenectomy without full consideration of potential consequences. Here we take a closer look, evaluating their general safety in this setting and with a closer look at thrombosis.”
Read the full article here.
Title: Beyond Platelet Counts: Assessing Safety of Post-Splenectomy TPO-RA Use in ITP
Authors: Ruah Alyamany, Damon E Houghton, Meera Sridharan, Rajiv K Pruthi, Surbhi Shah, Richard C. Godby, Alexandra P Wolanskyj-Spinner, Ronald S. Go
Stay updated on the latest scientific advancements with Hemostasis Today.
-
Jul 23, 2026, 15:43Lorna Knight: The Next Frontier in Sickle Cell Disease Is Access
-
Jul 23, 2026, 15:29Ben Kleinstiver: Overcoming a Major Barrier to Scalable Gene Editing
-
Jul 23, 2026, 15:28Modernizing DIC Diagnosis in Cirrhosis: Building an International Registry for Precision Hemostasi
-
Jul 23, 2026, 14:32Saneha Anjum Shaikh: Why Antibody Screening Must Be Standard Practice in Modern Blood Banking
-
Jul 23, 2026, 14:00Ron Vezina: Canadian Blood Services Issues Urgent Donation Appeal
-
Jul 23, 2026, 13:46Sebastian Szmit: Understanding Troponins in Modern Cardio-Oncology
-
Jul 23, 2026, 13:41Colleen Grady: Why Normal Hemoglobin Does Not Exclude Iron Deficiency
-
Jul 23, 2026, 13:22Jacob Kelly: AHA Review Highlights Coffee’s Cardiovascular Benefits
-
Jul 23, 2026, 13:01Sally Mandour: Automated Blood Indices Enhance IDA Diagnosis in Cirrhotic Patients